Content resistin plasma and nonspecific inflammation markers in patients with type 2 diabetes compensation from different diseases
Saved in:
| Date: | 2015 |
|---|---|
| Main Author: | A. M. Urbanovych |
| Format: | Article |
| Language: | English |
| Published: |
2015
|
| Series: | Actual problems of transport medicine: environment, occupational health, pathology |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0000594130 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
-
The blood leptin content and the activity of the zonal system response in patients with diabetes mellitus type 2 with different body weight and disease duration
by: B. M. Mankovskyi, et al.
Published: (2014) -
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: M. D. Tronko, et al.
Published: (2021) -
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: Tronko, M.D., et al.
Published: (2021) -
Cardiovascular disease among patients with type 2 diabetes: Role of homocysteine as an inflammatory marker
by: A. Sahu, et al.
Published: (2016) -
Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristic
by: Pamuk, G.E., et al.
Published: (2006)